Hematology — Medicare Part B billing by state
6 physician groups whose primary specialty is Hematology billed $8.3M to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| California | $4.4M | $4.4M | 2 | $2.2M | 313K | 9,195 | 156K |
| Pennsylvania | $2.5M | $2.5M | 1 | $2.5M | 109K | 7,928 | 109K |
| South Carolina | $755K | $714K | 1 | $714K | 9,469 | 4,355 | 9,469 |
| New Jersey | $549K | $576K | 1 | $576K | 130K | 2,347 | 130K |
| Texas | $135K | $136K | 1 | $136K | 2,219 | 1,176 | 2,219 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
5 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J0897 · Injection, denosumab, 1 mg | $1.3M | 71,340 | CAPASCNJTX |
| J9271 · Injection, pembrolizumab, 1 mg | $952K | 22,000 | CAPASCNJTX |
| J1569 · Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | $858K | 24,000 | CAPASCNJTX |
| A9595 · Piflufolastat f-18, diagnostic, 1 millicurie | $218K | 450 | CAPASCNJTX |
| J0517 · Injection, benralizumab, 1 mg | $210K | 1,590 | CAPASCNJTX |
| Q5106 · Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units top by services | $111K | 18,240 | CAPASCNJTX |
| J0885 · Injection, epoetin alfa, (for non-esrd use), 1000 units top by services | $76K | 13,217 | CAPASCNJTX |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | $62K | 71,250 | CAPASCNJTX |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | $52K | 139K | CAPASCNJTX |
| J9263 · Injection, oxaliplatin, 0.5 mg top by services | $3K | 56,200 | CAPASCNJTX |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $2K | 23,040 | CAPASCNJTX |
| J9267 · Injection, paclitaxel, 1 mg top by services | $1K | 14,362 | CAPASCNJTX |